M&A Deal Summary |
|
|---|---|
| Date | 2015-10-14 |
| Target | Scithera Microbial Technologies - Intellectual Property for Multiple Lysins |
| Sector | Information Technology |
| Buyer(s) | Phagelux |
| Sellers(s) | Scithera Microbial Technologies |
| Deal Type | Divestiture |
SEARCH BY
Phagelux, Inc. is a developer of anti-bacterial solutions across multiple fields utilizing various phage and phage-based technologies and solutions.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Information Technology M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: China M&A | 1 of 1 |
| Year: 2015 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-07-20 |
OmniLytics
Sandy, Utah, United States OmniLytics, Inc. is engaged in research and development of bacteriophage solutions for pathogen control in the fields of agriculture, food and water safety, and sanitation. |
Buy | - |
Scithera Microbial Technologies Ltd. is a provider of IT solutions for life science industry.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Information Technology M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: China M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 1 |
